AT227120T - Devices for intravaginal administration of testosterone and testosterone precursors - Google Patents

Devices for intravaginal administration of testosterone and testosterone precursors


Publication number
AT227120T AT98921701T AT98921701T AT227120T AT 227120 T AT227120 T AT 227120T AT 98921701 T AT98921701 T AT 98921701T AT 98921701 T AT98921701 T AT 98921701T AT 227120 T AT227120 T AT 227120T
Prior art keywords
intravaginal administration
Prior art date
Application number
Other languages
German (de)
Clare Passmore
Claire Gilligan
Original Assignee
Galen Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IE970333 priority Critical
Application filed by Galen Chemicals Ltd filed Critical Galen Chemicals Ltd
Priority to PCT/IE1998/000033 priority patent/WO1998050016A2/en
Publication of AT227120T publication Critical patent/AT227120T/en



    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
AT98921701T 1997-05-07 1998-05-07 Devices for intravaginal administration of testosterone and testosterone precursors AT227120T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IE970333 1997-05-07
PCT/IE1998/000033 WO1998050016A2 (en) 1997-05-07 1998-05-07 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors

Publications (1)

Publication Number Publication Date
AT227120T true AT227120T (en) 2002-11-15



Family Applications (1)

Application Number Title Priority Date Filing Date
AT98921701T AT227120T (en) 1997-05-07 1998-05-07 Devices for intravaginal administration of testosterone and testosterone precursors

Country Status (15)

Country Link
US (1) US6416780B1 (en)
EP (1) EP0981327B1 (en)
JP (1) JP2001524124A (en)
CN (1) CN1184957C (en)
AT (1) AT227120T (en)
AU (1) AU741482B2 (en)
CA (1) CA2288046C (en)
DE (1) DE69809222T2 (en)
DK (1) DK0981327T3 (en)
ES (1) ES2187024T3 (en)
IL (1) IL132702D0 (en)
NO (1) NO995419L (en)
NZ (1) NZ501236A (en)
PT (1) PT981327E (en)
WO (1) WO1998050016A2 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
WO2003080018A1 (en) * 2002-03-27 2003-10-02 Galen (Chemicals) Limited Intravaginal matrix drug delivery devices
US8404272B2 (en) * 2003-06-26 2013-03-26 Poly-Med, Inc. Fiber-reinforced composite rings for intravaginal controlled drug delivery
US8399013B2 (en) * 2003-06-26 2013-03-19 Poly-Med, Inc. Partially absorbable fiber-reinforced composites for controlled drug delivery
MY144968A (en) 2005-04-11 2011-11-30 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their uses as therapeutic agents
AR053710A1 (en) 2005-04-11 2007-05-16 Xenon Pharmaceuticals Inc Spiroheterocyclic compounds and their uses as therapeutic agents
ES2400091T3 (en) * 2005-08-11 2013-04-05 Massachusetts Institute Of Technology Intravesical drug delivery device and method
US8795711B2 (en) 2006-03-31 2014-08-05 Mati Therapeutics Inc. Drug delivery methods, structures, and compositions for nasolacrimal system
CN101631546A (en) 2006-10-12 2010-01-20 泽农医药公司 Use of spiro-oxindole compounds as therapeutic agents
AU2008335077B2 (en) * 2007-12-11 2014-05-29 Massachusetts Institute Of Technology Implantable drug delivery device ant) methods for treatment of the bladder and other body vestcles or lumens
EA031017B1 (en) * 2008-02-04 2018-11-30 Ферринг Б.В. Method for support or substitution of yellow body phase
US9034365B2 (en) 2008-05-20 2015-05-19 Poly-Med, Inc. Biostable, multipurpose, microbicidal intravaginal devices
CN102176931B (en) * 2008-08-09 2015-03-04 麻省理工学院 Implantable drug delivery device and methods of treating male genitourinary and surrounding tissues
CN106928247A (en) 2008-10-17 2017-07-07 泽农医药公司 Spiral shell oxindole compounds and its purposes as therapeutic agent
CA2741024A1 (en) 2008-10-17 2010-04-22 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
US20110269788A1 (en) 2008-12-29 2011-11-03 Xenon Pharmaceuticals Inc. Spiro-oxindole-derivatives as sodium channel blockers
EP2445570B1 (en) 2009-06-26 2012-11-21 Taris Biomedical, Inc. Implantable drug delivery devices and methods of making the same
US9017312B2 (en) * 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
AR077252A1 (en) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomers of compounds of espirooxindol and their uses as therapeutic agents
MY165579A (en) 2009-10-14 2018-04-05 Xenon Pharmaceuticals Inc Synthetic methods for spiro-oxindole compounds
MX343215B (en) 2010-02-26 2016-10-27 Xenon Pharmaceuticals Inc Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents.
SG191893A1 (en) 2011-01-10 2013-08-30 Taris Biomedical Inc Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
RU2598057C2 (en) 2011-02-04 2016-09-20 ТАРИС Биомедикал ЛЛК Implantable device for controlled release of drug with low solubility
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
CN103889401B (en) 2011-08-29 2017-10-13 Qlt公司 Sustained release delivery activating agent is to treat glaucoma and Bulbi hypertonia
WO2013064983A1 (en) 2011-10-31 2013-05-10 Xenon Pharmaceuticals Inc. Benzenesulfonamide compounds and their use as therapeutic agents
JP2016514459A (en) 2013-03-15 2016-05-23 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア A dual-reactive potent Kunitz inhibitor for fibrinolysis
EP2968880A1 (en) 2013-03-15 2016-01-20 TARIS Biomedical LLC Drug delivery devices with drug-permeable component and methods
CN104546668B (en) * 2013-10-23 2019-03-05 国家卫生计生委科学技术研究所 Liquid silastic is the preparation and application of the medicine sustained and controlled release system of carrier
DK2982352T3 (en) * 2014-06-28 2018-11-26 Laboratorios Andromaco S A Cervically pessar containing progesteron for extended, long and continuous release used to prevent early births
TW201636017A (en) 2015-02-05 2016-10-16 Teva Pharmaceuticals Int Gmbh In topical formulation of the compound spiroindolone treatment of postherpetic neuralgia
KR20180129783A (en) 2016-02-19 2018-12-05 피닉스 몰레큘라 디자인스 Carboxamide derivatives useful as RSK inhibitors
KR20190007050A (en) 2016-05-20 2019-01-21 제논 파마슈티칼스 인크. Benzenesulfonamide compounds and their use as therapeutic agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920805A (en) * 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
GB2079158B (en) * 1980-06-09 1985-01-09 Ahi Operations Ltd Intra-vaginal devices
US5340585A (en) * 1991-04-12 1994-08-23 University Of Southern California Method and formulations for use in treating benign gynecological disorders

Also Published As

Publication number Publication date
PT981327E (en) 2003-02-28
EP0981327A2 (en) 2000-03-01
EP0981327B1 (en) 2002-11-06
DE69809222T2 (en) 2003-08-14
US6416780B1 (en) 2002-07-09
NO995419D0 (en) 1999-11-05
CN1255056A (en) 2000-05-31
DK0981327T3 (en) 2003-03-10
DK981327T3 (en)
IL132702D0 (en) 2001-03-19
CN1184957C (en) 2005-01-19
CA2288046A1 (en) 1998-11-12
WO1998050016A3 (en) 1999-02-04
DE69809222D1 (en) 2002-12-12
ES2187024T3 (en) 2003-05-16
JP2001524124A (en) 2001-11-27
WO1998050016A2 (en) 1998-11-12
AU741482B2 (en) 2001-11-29
NZ501236A (en) 2002-02-01
NO995419L (en) 2000-01-07
AU7446998A (en) 1998-11-27
CA2288046C (en) 2006-10-03

Similar Documents

Publication Publication Date Title
DE69824175D1 (en) Refillable stent and administration system
DE19580865D2 (en) Implant, implant procedures and application device
DE69826290D1 (en) Pharmaceutical compositions for the controlled release of active substances
DE69909056D1 (en) Atomizer and nozzle for use
DE69822833D1 (en) Surgical sick bear
DE69530939D1 (en) Foamable formulation and foamable
DE69720316D1 (en) Device for receiving and releasing of biologically active substances
DE69518509D1 (en) Androstanes and pregnane for allosteric modulation of the GABA receptor
ID20140A (en) Equipment for pengorientasian and long shaped object placement for drug pendispensian
FI963292A (en) The absorbent body and the device for the preparation of
DE69533180D1 (en) Steroid receptor modulator compounds and methods
DE69825420D1 (en) Wireless transmission system and operational procedures for containment was
DE69511566T2 (en) Triphenylethylene for prevention and treatment of osteoporosis
DE69805202T2 (en) Using benzhydrylsulfinylderivaten for treatment of drug schläfigkeit origin
DE69306969T2 (en) Therapeutic anti-HIV oligonucleotide and drug
DE69813274D1 (en) Catheter for perfusion and okklusion
DE69520882D1 (en) Pharmaceutical composition comprising amoxycillin and kaliumclavunalat
ID25504A (en) Prevention and treatment of diseases amiloidogenik
DE69825251D1 (en) Polarizer and flüssikristallanzeigeelement
AT231971T (en) Test-kit and devices
DE69819748D1 (en) Medicines blow for treatment of dysmenorrhea and premature
DE69910803D1 (en) Fentanylzusammensetzung for treatment of acute pain
DE69407061T2 (en) Dispensing device for electrical transmission of drugs
DE69708149D1 (en) Double-chamber container and single chamber for
DE69528057D1 (en) Tocopherolzusammensetzungen for delivery of biologically active substances

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0981327

Country of ref document: EP

REN Ceased due to non-payment of the annual fee